A detailed history of Garrett Investment Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Garrett Investment Advisors LLC holds 3,159 shares of LLY stock, worth $2.46 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
3,159
Previous 2,717 16.27%
Holding current value
$2.46 Million
Previous $2.46 Million 13.79%
% of portfolio
0.3%
Previous 0.31%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$772.14 - $960.02 $341,285 - $424,328
442 Added 16.27%
3,159 $2.8 Million
Q2 2024

Jul 10, 2024

BUY
$724.87 - $909.04 $1.24 Million - $1.56 Million
1,716 Added 171.43%
2,717 $2.46 Million
Q1 2024

Apr 12, 2024

BUY
$592.2 - $792.28 $8,290 - $11,091
14 Added 1.42%
1,001 $778,000
Q4 2023

Jan 05, 2024

SELL
$525.19 - $619.13 $162,808 - $191,930
-310 Reduced 23.9%
987 $575,000
Q3 2023

Oct 13, 2023

BUY
$434.7 - $599.3 $217,784 - $300,249
501 Added 62.94%
1,297 $696,000
Q2 2023

Jul 10, 2023

SELL
$350.74 - $468.98 $9,119 - $12,193
-26 Reduced 3.16%
796 $373,000
Q3 2022

Oct 18, 2022

BUY
$296.48 - $337.87 $17,492 - $19,934
59 Added 7.73%
822 $266,000
Q2 2022

Jul 27, 2022

BUY
$278.73 - $327.27 $5,017 - $5,890
18 Added 2.42%
763 $247,000
Q1 2022

Apr 04, 2022

SELL
$234.69 - $291.66 $8,918 - $11,083
-38 Reduced 4.85%
745 $213,000
Q4 2021

Jan 14, 2022

BUY
$224.85 - $279.04 $176,057 - $218,488
783 New
783 $216,000
Q3 2021

Oct 07, 2021

SELL
$221.6 - $272.71 $397,772 - $489,514
-1,795 Closed
0 $0
Q2 2021

Jul 21, 2021

SELL
$180.55 - $233.54 $4,694 - $6,072
-26 Reduced 1.43%
1,795 $412,000
Q1 2021

Apr 20, 2021

BUY
$164.32 - $212.72 $10,187 - $13,188
62 Added 3.52%
1,821 $340,000
Q4 2020

Jan 26, 2021

BUY
$130.46 - $172.63 $229,479 - $303,656
1,759 New
1,759 $297,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Garrett Investment Advisors LLC Portfolio

Follow Garrett Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garrett Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garrett Investment Advisors LLC with notifications on news.